US2008216562A1PendingUtilityA1

Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof

Assignee: TEVA PHARMACEUTICALS USA INC FPriority: Dec 27, 2005Filed: May 6, 2008Published: Sep 11, 2008
Est. expiryDec 27, 2025(expired)· nominal 20-yr term from priority
A61P 13/00C07D 405/06C07D 307/79C07D 207/09C07D 207/48
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided are darifenacin hydrobromide free of oxidized darifenacin, and processes for the preparation thereof.

Claims

exact text as granted — not AI-modified
1 . An HPLC method for determining the presence and level of oxidized darifenacin and salts thereof in a darifenacin hydrobromide sample comprising: (a) combining a darifenacin hydrobromide sample with a mixture of acetonitrile:water in a ratio of about 1:1, to obtain a solution; (b) injecting the solution into a 150×4.6 mm×5.0 μm Phenyl C6 column; (c) eluting the sample from the column using a mixture of acetonitrile:water in a ratio of 9:1 and buffer as an eluent; and (d) measuring the oxidized darifenacin content in the sample with a UV detector. 
   
   
       2 . A process of determining the presence of a compound of the following formula I 
     
       
         
         
             
             
         
       
     
     in a sample comprising the compound of formula I and a compound of the following formula II 
     
       
         
         
             
             
         
       
     
     by a process comprising carrying out HPLC or TLC with the compound of formula I as a reference marker, wherein Y is a leaving group selected from the group consisting of Cl, I, brosyl, mesyl, tosyl, trifluoroacetyl, and trifluoromethansulfonyl. 
   
   
       3 . The process of  claim 2 , comprising: (a) measuring by HPLC or TLC the relative retention time corresponding to the compound of formula I in a reference marker sample; (b) determining by HPLC or TLC the relative retention time corresponding to the compound of formula I in a sample comprising a compound of formula I and a compound of formula II; and (c) determining the relative retention time of the compound of formula I in the sample by comparing the relative retention time of step (a) to the relative retention time of step (b). 
   
   
       4 . The process of  claim 3 , wherein Y is Cl. 
   
   
       5 . A process of determining the amount of a compound of the following formula I 
     
       
         
         
             
             
         
       
       in a sample comprising the compound of formula I and a compound of the following formula II 
     
     
       
         
         
             
             
         
       
       by a process comprising carrying out an HPLC with the compound of formula I as a reference standard, wherein Y is a leaving group selected from the group consisting of Cl, I, brosyl, mesyl, tosyl, trifluoroacetyl, and trifluoromethansulfonyl. 
     
   
   
       6 . The process of  claim 5 , comprising: (a) measuring by HPLC the area under a peak corresponding to a compound of formula I in a reference standard comprising a known amount of the compound of formula I; (b) measuring by HPLC the area under a peak corresponding to a compound of formula I in a sample comprising a compound of formula I and a compound of formula II; and (c) determining the amount of the compound of formula I in the sample by comparing the area of step (a) to the area of step (b). 
   
   
       7 . The process of  claim 6 , wherein Y is Cl. 
   
   
       8 . The HPLC method of  claim 3 , comprising: (a) combining a sample of the compound of formula I with a mixture of acetonitrile:water in a ration of about 1:1, to obtain a solution; (b) injecting the solution into a 250×4.6 mm×0.5 μm C18 column; (c) eluting the sample from the column using a mixture of acetonitrile and buffer as an eluent; and (d) measuring the amount of the compound of formula I in the sample with a UV detector at a wavelength of 215 nm. 
   
   
       9 . the method of  claim 8 , wherein Y is Cl. 
   
   
       10 . The HPLC method of  claim 6 , comprising: (a) combining a sample of the compound of formula I with a mixture of acetonitrile:water in a ratio of about 1:1, to obtain a solution; (b) injecting the solution into a 250×4.6 mm×0.5 μm C18 column; (c) eluting the sample from the column using a mixture of acetonitrile and buffer as an eluent; and (d) measuring the amount of the compound of formula I in the sample with a UV detector at a wavelength of 215 nm. 
   
   
       11 . The method of  claim 10 , wherein Y is Cl.

Join the waitlist — get patent alerts

Track US2008216562A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.